Even though spring has sprung, we traded lab coats and circles for snow gear and diamond runs during Orna's Ski and Snowboard Day! #Ornacorns had a great time on the slopes at Loon Mountain in NH. ❄️
Orna Therapeutics’ Post
More Relevant Posts
-
Calling all Staff Accountants: Orna's Finance team is hiring! This is a great opportunity to break into biotech and gain broad experience. Know anyone who might be interested? Apply here: https://lnkd.in/eQPiUCtA #hiring
-
Orna’s acquisition of ReNAgade Therapeutics is a testament to our dedication to unlocking an entirely new and promising class of RNA-based medicines. Together, we are more than the sum of our platforms — with the potential to drive better efficacy and patient outcomes compared to current cell therapy and gene editing approaches — addressing massive unmet needs in diseases such as sickle cell and thalassemia. Read more here: https://lnkd.in/eYHYAfkf #RNA #Biotech #Biopharma
-
-
In case you missed this morning’s news, Orna acquired ReNAgade Therapeutics — a significant step forward for the field of RNA-targeted therapies and for modalities with continued unmet need including CAR therapy and gene editing. We are leveraging deep knowledge and a range of highly innovative capabilities to solve the most pressing challenges in drug development today. Read more here: https://lnkd.in/eYHYAfkf #RNA #Biotech #Biopharma #Science
-
-
Today marks a new chapter for Orna and for the future of RNA-based medicines as we announce our acquisition of ReNAgade Therapeutics. This strategic move unifies two industry-leading circles with the knowhow to significantly expand circular RNA engineering and delivery technologies and advance in vivo CAR and gene editing approaches for a range of diseases. Join us in welcoming Amit Munshi as Chief Executive Officer as Tom Barnes, PhD transitions to Co-Chair of our Scientific Advisory Board. Read more here: https://lnkd.in/eYHYAfkf #Biopharma #Science #Biotech
-
-
Orna is Baltimore-bound! Be sure to catch us at #ASGCT2024, where we’ll present several posters highlighting our industry-leading circular RNA technology (oRNA). For more info: https://lnkd.in/dHgkVjV
-
-
Thank you Matthew Pillar and Anna Rose Welch for a great Business of Biotech conversation with our CEO Tom Barnes, covering the journey of an academic in biotech and the immense potential of circles in #RNA 🎧 Listen to the full conversation on your favorite podcast platform or on the website here: https://lnkd.in/eT-qwEzt
-
What a wheel-y awesome night we had showing off our moves and bonding over some serious fun! Our #Ornacorns laced up and skated circles around the Chez-Vous Roller Skating Rink here in Boston. 🛼 From breakthroughs in the lab to breaking it down on the floor, let's keep the momentum going, on and off the rink!
-
-
We are excited to announce that Frank Neumann, M.D., Ph.D., will join the Orna team as Chief Medical Officer later this month. Dr. Neumann will bring deep industry expertise, spanning proof-of-concept to clinical evaluation and beyond, as we reshape RNA therapeutics to realize new treatment possibilities in hematological malignancies, autoimmune diseases and beyond. Read more: https://lnkd.in/eHrNuqUf
-
